222 related articles for article (PubMed ID: 31100455)
1. Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis.
Spergel JM; Elci OU; Muir AB; Liacouras CA; Wilkins BJ; Burke D; Lewis MO; Brown-Whitehorn T; Cianferoni A
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):328-336.e7. PubMed ID: 31100455
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.
Wright BL; Fernandez-Becker NQ; Kambham N; Purington N; Cao S; Tupa D; Zhang W; Sindher SB; Rank MA; Kita H; Katzka DA; Shim KP; Bunning BJ; Doyle AD; Jacobsen EA; Tsai M; Boyd SD; Manohar M; Chinthrajah RS
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1151-1159.e14. PubMed ID: 32434067
[TBL] [Abstract][Full Text] [Related]
3. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R; Newbury R; Fox L; Bastian J; Aceves S
Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
[TBL] [Abstract][Full Text] [Related]
4. Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
Petroni D; Bégin P; Bird JA; Brown-Whitehorn T; Chong HJ; Fleischer DM; Gagnon R; Jones SM; Leonard S; Makhija MM; Oriel RC; Shreffler WG; Sindher SB; Sussman GL; Yang WH; Bee KJ; Bois T; Campbell DE; Green TD; Rutault K; Sampson HA; Wood RA
JAMA Pediatr; 2024 Apr; 178(4):345-353. PubMed ID: 38407859
[TBL] [Abstract][Full Text] [Related]
5. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.
Kliewer KL; Murray-Petzold C; Collins MH; Abonia JP; Bolton SM; DiTommaso LA; Martin LJ; Zhang X; Mukkada VA; Putnam PE; Kellner ES; Devonshire AL; Schwartz JT; Kunnathur VA; Rosenberg CE; Lyles JL; Shoda T; Klion AD; Rothenberg ME
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):803-815. PubMed ID: 37336228
[TBL] [Abstract][Full Text] [Related]
6. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial.
Kliewer KL; Gonsalves N; Dellon ES; Katzka DA; Abonia JP; Aceves SS; Arva NC; Besse JA; Bonis PA; Caldwell JM; Capocelli KE; Chehade M; Cianferoni A; Collins MH; Falk GW; Gupta SK; Hirano I; Krischer JP; Leung J; Martin LJ; Menard-Katcher P; Mukkada VA; Peterson KA; Shoda T; Rudman Spergel AK; Spergel JM; Yang GY; Zhang X; Furuta GT; Rothenberg ME
Lancet Gastroenterol Hepatol; 2023 May; 8(5):408-421. PubMed ID: 36863390
[TBL] [Abstract][Full Text] [Related]
7. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.
Gonsalves N; Yang GY; Doerfler B; Ritz S; Ditto AM; Hirano I
Gastroenterology; 2012 Jun; 142(7):1451-9.e1; quiz e14-5. PubMed ID: 22391333
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
[TBL] [Abstract][Full Text] [Related]
9. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis?
Ravi K; Talley NJ; Smyrk TC; Katzka DA; Kryzer L; Romero Y; Arora AS; Alexander JA
Dig Dis Sci; 2011 Jul; 56(7):1981-6. PubMed ID: 21298480
[TBL] [Abstract][Full Text] [Related]
10. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Gupta SK; Lan L; Williams J; Hirano I
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):666-673.e8. PubMed ID: 29902649
[TBL] [Abstract][Full Text] [Related]
12. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy.
Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Shaheen NJ; Woosley JT
Mod Pathol; 2015 Mar; 28(3):383-90. PubMed ID: 25216228
[TBL] [Abstract][Full Text] [Related]
13. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.
Safroneeva E; Pan Z; King E; Martin LJ; Collins MH; Yang GY; Capocelli KE; Arva NC; Abonia JP; Atkins D; Bonis PA; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Schoepfer AM; Spergel JM; Wershil BK; Rothenberg ME; Aceves SS; Furuta GT;
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):766-775.e4. PubMed ID: 34062314
[TBL] [Abstract][Full Text] [Related]
14. Food-Specific IgG4 Is Elevated Throughout the Upper Gastrointestinal Tract in Eosinophilic Esophagitis.
Masuda MY; LeSuer WE; Horsley-Silva JL; Putikova A; Buras MR; Gibson JB; Pyon GC; Simmons TD; Doyle AD; Wright BL
Dig Dis Sci; 2023 Jun; 68(6):2406-2413. PubMed ID: 36973521
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
[TBL] [Abstract][Full Text] [Related]
16. Correlation of ALOX15 expression with eosinophilic or reflux esophagitis in a cohort of pediatric patients with esophageal eosinophilia.
Matoso A; Allen D; Herzlinger M; Ferreira J; Chen S; Lu S; Fabre V; Monahan R; Yang D; Noble L; Mangray S; Resnick MB
Hum Pathol; 2014 Jun; 45(6):1205-12. PubMed ID: 24742828
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts.
Mondoulet L; Kalach N; Dhelft V; Larcher T; Delayre-Orthez C; Benhamou PH; Spergel J; Sampson HA; Dupont C
Clin Exp Allergy; 2017 Dec; 47(12):1640-1647. PubMed ID: 28960628
[TBL] [Abstract][Full Text] [Related]
19. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis.
Nielsen JA; Lager DJ; Lewin M; Rendon G; Roberts CA
Am J Gastroenterol; 2014 Apr; 109(4):515-20. PubMed ID: 24445569
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil counts in upper digestive mucosa of Western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings.
Kalach N; Huvenne H; Gosset P; Papadopoulos S; Dehecq E; Decoster A; Creusy C; Dupont C
J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):175-82. PubMed ID: 20890222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
